Besonderheiten beachten
In: Deutsche Dermatologie: Organ des Berufsverbands der Deutschen Dermatologen, Band 71, Heft 4, S. 314-325
ISSN: 2731-7706
10 Ergebnisse
Sortierung:
In: Deutsche Dermatologie: Organ des Berufsverbands der Deutschen Dermatologen, Band 71, Heft 4, S. 314-325
ISSN: 2731-7706
In: Deutsche Dermatologie: Organ des Berufsverbands der Deutschen Dermatologen, Band 71, Heft 3, S. 224-239
ISSN: 2731-7706
In: Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, Band 13, Heft 45
ISSN: 1424-4020
In: Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, Band 15, Heft 5253
ISSN: 1424-4020
In: Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, Band 14, Heft 15
ISSN: 1424-4020
In: Annals of work exposures and health: addressing the cause and control of work-related illness and injury, Band 61, Heft 7, S. 822-835
ISSN: 2398-7316
In: Muraro , A , Lemanske , R F , Hellings , P W , Akdis , C A , Bieber , T , Casale , T B , Jutel , M , Ong , P Y , Poulsen , L K , Schmid-Grendelmeier , P , Simon , H-U , Seys , S F & Agache , I 2016 , ' Precision medicine in patients with allergic diseases : Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology ' , The Journal of allergy and clinical immunology , vol. 137 , no. 5 , pp. 1347-58 . https://doi.org/10.1016/j.jaci.2016.03.010
In this consensus document we summarize the current knowledge on major asthma, rhinitis, and atopic dermatitis endotypes under the auspices of the PRACTALL collaboration platform. PRACTALL is an initiative of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology aiming to harmonize the European and American approaches to best allergy practice and science. Precision medicine is of broad relevance for the management of asthma, rhinitis, and atopic dermatitis in the context of a better selection of treatment responders, risk prediction, and design of disease-modifying strategies. Progress has been made in profiling the type 2 immune response-driven asthma. The endotype driven approach for non-type 2 immune response asthma, rhinitis, and atopic dermatitis is lagging behind. Validation and qualification of biomarkers are needed to facilitate their translation into pathway-specific diagnostic tests. Wide consensus between academia, governmental regulators, and industry for further development and application of precision medicine in management of allergic diseases is of utmost importance. Improved knowledge of disease pathogenesis together with defining validated and qualified biomarkers are key approaches to precision medicine.
BASE
In this consensus document we summarize the current knowledge on major asthma, rhinitis, and atopic dermatitis endotypes under the auspices of the PRACTALL collaboration platform. PRACTALL is an initiative of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology aiming to harmonize the European and American approaches to best allergy practice and science. Precision medicine is of broad relevance for the management of asthma, rhinitis, and atopic dermatitis in the context of a better selection of treatment responders, risk prediction, and design of disease-modifying strategies. Progress has been made in profiling the type 2 immune response-driven asthma. The endotype driven approach for non-type 2 immune response asthma, rhinitis, and atopic dermatitis is lagging behind. Validation and qualification of biomarkers are needed to facilitate their translation into pathway-specific diagnostic tests. Wide consensus between academia, governmental regulators, and industry for further development and application of precision medicine in management of allergic diseases is of utmost importance. Improved knowledge of disease pathogenesis together with defining validated and qualified biomarkers are key approaches to precision medicine.
BASE
In: Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, Band 17, Heft 32
ISSN: 1424-4020
In: Zuberbier , T , Abdul Latiff , A H , Abuzakouk , M , Aquilina , S , Asero , R , Baker , D , Ballmer-Weber , B , Bangert , C , Ben-Shoshan , M , Bernstein , J A , Bindslev-Jensen , C , Brockow , K , Brzoza , Z , Chong Neto , H J , Church , M K , Criado , P R , Danilycheva , I V , Dressler , C , Ensina , L F , Fonacier , L , Gaskins , M , Gáspár , K , Gelincik , A , Giménez-Arnau , A , Godse , K , Gonçalo , M , Grattan , C , Grosber , M , Hamelmann , E , Hébert , J , Hide , M , Kaplan , A , Kapp , A , Kessel , A , Kocatürk , E , Kulthanan , K , Larenas-Linnemann , D , Lauerma , A , Leslie , T A , Magerl , M , Makris , M , Meshkova , R Y , Metz , M , Micallef , D , Mortz , C G , Nast , A , Oude-Elberink , H , Pawankar , R , Pigatto , P D , Ratti Sisa , H , Rojo Gutiérrez , M I , Saini , S S , Schmid-Grendelmeier , P , Sekerel , B E , Siebenhaar , F , Siiskonen , H , Soria , A , Staubach-Renz , P , Stingeni , L , Sussman , G , Szegedi , A , Thomsen , S F , Vadasz , Z , Vestergaard , C , Wedi , B , Zhao , Z & Maurer , M 2022 , ' The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria ' , Allergy: European Journal of Allergy and Clinical Immunology , vol. 77 , no. 3 , pp. 734-766 . https://doi.org/10.1111/all.15090
This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GA²LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), the European Dermatology Forum (EDF; EuroGuiDerm), and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology with the participation of 64 delegates of 50 national and international societies and from 31 countries. The consensus conference was held on 3 December 2020. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell–driven disease that presents with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous or inducible urticaria is disabling, impairs quality of life, and affects performance at work and school. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert-guided and evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.
BASE